课题基金 / 基金详情

项目摘要

项目成果

ERIK K FLEMINGTON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Epstein-Barr virus (EBV) is highly penetrant in AIDS-associated non-Hodgkin's lymphomas where it is a key driver of the tumor phenotype. While EBV latency genes are critical for facilitating the tumor phenotype, the switch from latency to the lytic cycle is a critical aspect of a successful EBV infection program. As a result, the mechanisms driving this switch have been topics of active investigation over the years. Although EBV reactivation can be achieved in tissue culture through stimulation of the B-cell receptor (with anti-Ig) or the TGF-beta receptor (with ectopic TGF-beta), it is uncertain how common such events are in EBV-infected lymphocytes in vivo (work from David Thorley-Lawson's lab). The overarching hypothesis of this application is that EBV has evolved with a sensing mechanism for latently infected B-cells to detect when they encounter an epithelial cell environment. This model proposes that environmental cues from the oral/tonsil epithelium (in the late stages of the germinal center reaction, for example) trigger reactivation in B-cells, thereby facilitating the B-cell to epithelial cell viral transfer that is a fundamental first step n oral epithelial plaque formation and host- to-host transmission.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EBV reactivation causes widespread host de novo promoter transcription and transcriptional interference
  • 批准号:
    10647826
  • 项目类别:
  • 资助金额:
    $41.28万
  • 财政年份:
    2022
  • 负责人:
    ERIK K FLEMINGTON
  • 依托单位:
EBV reactivation causes widespread host de novo promoter transcription and transcriptional interference
  • 批准号:
    10548370
  • 项目类别:
  • 资助金额:
    $42.13万
  • 财政年份:
    2022
  • 负责人:
    ERIK K FLEMINGTON
  • 依托单位:
Programmed splicing derangement as new EBV host cell shut-off mechanism
  • 批准号:
    10580068
  • 项目类别:
  • 资助金额:
    $41.79万
  • 财政年份:
    2022
  • 负责人:
    ERIK K FLEMINGTON
  • 依托单位:
Programmed splicing derangement as new EBV host cell shut-off mechanism
  • 批准号:
    10446536
  • 项目类别:
  • 资助金额:
    $42.65万
  • 财政年份:
    2022
  • 负责人:
    ERIK K FLEMINGTON
  • 依托单位:
海外基金